Study of adrenocortical cancer in a Brazilian group
Part of Cancer, Hormones & metabolism clinical trials.
This study looks at patients with adrenocortical carcinoma, a rare type of adrenal gland cancer, to learn more about the disease and how it affects people in Brazil. You may join if you were diagnosed or had a recurrence in 2000 or later and have had a clinic visit at the participating hospital.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with adrenocortical carcinoma.
- You have had at least one clinic visit at the study hospital.
- Your diagnosis or recurrence happened in the year 2000 or later.
- Your medical records have enough information for the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is a registry that collects information from people diagnosed with adrenocortical carcinoma (a rare cancer of the adrenal gland). It can help doctors understand the disease and improve future care by tracking outcomes and treatments.
This study follows adults with a new adrenal diagnosis to learn how adrenal diseases behave over time. It may help doctors better understand these conditions and improve future care.
This study looks at patients with adrenal cortex carcinoma who were treated at Strasbourg University Hospital. It aims to better understand the condition and its outcomes.
This trial tests whether combining camrelizumab (an immune treatment) with apatinib (a targeted drug) can shrink recurrent or metastatic adrenal cancer after standard treatment didn’t work. It may help some people control tumor growth when other treatments have already been tried.
This study is collecting information from people with certain adrenal gland tumors (pheochromocytoma, paraganglioma, or adrenocortical tumor). It aims to learn more about these conditions, which may help improve future care. Both living and deceased patients can be included.
This study looks at adrenal tumors found on imaging (scans) to better understand what causes them and how they might be treated. If you have an adrenal tumor on a scan, this trial may be looking to enroll you for that purpose.
Hear when a new Carcinoma Adrenal trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.